Clinical Trials Browser

Phase 2 × Cognitive Dysfunction × Infliximab × Clear all

NCT06136546 2025-05-07

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Phase 2 Recruiting

Depression, Depressive Disorder, Major, Inflammation, Cognitive Dysfunction